Vaccines drive meningitis cases to record low

Jane Kirby
Friday 24 April 2009 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The number of children suffering from the three main strains of meningitis has fallen to a record low, the Government said yesterday.

Since the Hib (Haemophilus influenzae type b) vaccine was introduced in 1992, cases of the disease, which can cause meningitis, have dropped by 99 per cent. Before its introduction, there were about 800 cases a year but that hit a record low last year of just 12 cases among children under five.

Meanwhile, cases of meningitis C have also fallen thanks to the meningitis C vaccine, introduced in 1999. Before the jab was developed, there were about 700 cases per year but now there is less than one per year.

Deaths from the disease have also fallen from about 79 to an average of less than one death a year. The introduction of the vaccine against pneumococcal disease, which can cause pneumococcal meningitis, means that cases have fallen from about 300 per year to about 40.

It is estimated that more than 900 serious cases have been prevented, saving more than 50 lives.

Experts hope to develop a vaccine against the least common type of meningitis – meningitis B – over the next three years. The bacterial forms of meningitis cause death in about 10 per cent of cases. Those who survive can suffer a range of disabilities including loss of hearing, brain damage, paralysis and seizures.

Professor David Salisbury, the immunisation director at the Department of Health, said: "According to the World Health Organisation, vaccination sits alongside clean water as the public health measure that's had the biggest positive impact on the world's health."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in